Unknown NA INTERVENTIONAL 3-arm NCT03484611

Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

Sponsor: Cairo University

Interventions Embryo transfer GnRH antagonist Gonadotropins Human chorionic gonadotropin Progesterone

Updated 5 times since 2018 Last updated: Mar 26, 2018 Started: Jan 31, 2013 Primary completion: Apr 30, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Invitro Fertilizaion and is currently ongoing. Cairo University leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Apr 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
May 2018 — Apr 2020 [monthly]

Recruiting NA

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt